Skip to main content
. 2024 Dec 5;14(23):2744. doi: 10.3390/diagnostics14232744

Figure 10.

Figure 10

CRISPR reaction evaluating viability of RPA at three timepoints, 10, 20, 30 min, and three dilutions, undiluted, 1/10 and 1/100, alongside no-DNA control.